RecruitingNCT07092540
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
Sponsor
University of Rochester
Enrollment
105 participants
Start Date
May 30, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the BABY DUCHENNE study is to evaluate the natural history and characterize the early clinical outcomes in very young children (0-3 years) with Duchenne muscular dystrophy (DMD) identified by newborn screening programs.
Eligibility
Sex: MALEMin Age: 0 DaysMax Age: 3 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with duchenne muscular dystrophy (dmd). The study is currently recruiting participants at 1 location. People eligible for this study include men aged 0 Days to 3 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07092540
Related Trials
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
NCT071729711 location
Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
NCT076747589 locations
A Remote Study Using Technology to Assess Outcomes in DMD
NCT074230261 location
Duchenne Electronic Health Record Study
NCT0760939410 locations
Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
NCT076084321 location